Dr. Yige Bao: Perioperative Personalized Treatment of UTUC Based on ADC Drugs and the West China Experience

Dr. Yige Bao: Perioperative Personalized Treatment of UTUC Based on ADC Drugs and the West China Experience

Upper tract urothelial carcinoma (UTUC), encompassing renal pelvic and ureteral cancers, is relatively rare, with unique characteristics in the Chinese population, such as distinct disease features and molecular biology profiles. The 8th West China Uro-Oncology Tianfu Academic Conference, recently held in Chengdu, provided a platform to discuss how to better address the challenges in UTUC treatment and improve patient outcomes. In this event, Oncology Frontier interviewed Dr. Yige Bao from West China Hospital of Sichuan University, who shared insights into personalized perioperative treatment of UTUC with ADC drugs and the hospital's clinical experiences.
The 8th West China Uro-Oncology Tianfu Academic Conference丨Dr. Hongzhen Li: Advances in Radiotherapy for Urothelial Carcinoma

The 8th West China Uro-Oncology Tianfu Academic Conference丨Dr. Hongzhen Li: Advances in Radiotherapy for Urothelial Carcinoma

Urothelial carcinoma (UC) is one of the most common malignant tumors of the urinary system, encompassing bladder cancer, renal pelvic cancer, and ureteral cancer. Radiotherapy, as a critical treatment modality for tumors, has gained prominence in the comprehensive treatment of UC, offering hope for improved survival outcomes. During the 8th West China Urologic Oncology Academic Conference held in Chengdu, Oncology Frontier invited Dr. Hongzhen Li from Peking University First Hospital to share the latest advancements in radiotherapy for UC.
2024 WAAW丨Dr. Pengfei Shen: Why Urinary Tract Infections Trouble Women？

2024 WAAW丨Dr. Pengfei Shen: Why Urinary Tract Infections Trouble Women？

The third week of every November marks World Antimicrobial Awareness Week (WAAW). This year, WAAW adopts the theme: "Educate, Advocate, Act," aiming to raise public awareness about antimicrobial drugs, advocate for their appropriate use, and encourage action to combat antimicrobial resistance (AMR). In response to this call, Oncology Frontier invited Dr. Pengfei Shen from West China Hospital of Sichuan University to provide an informative overview of female urinary tract infections (UTIs), exploring why women are more prone to these infections, common symptoms, frequently used antibiotics, and the importance of responsible medication use to prevent antibiotic resistance.
CCHIO 2024丨Dr. Qingbo Wang: Comprehensive Treatment Strategies for Tuberculosis-Associated Lung Cancer

CCHIO 2024丨Dr. Qingbo Wang: Comprehensive Treatment Strategies for Tuberculosis-Associated Lung Cancer

At the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO), during the Infectious Tumors Subcommittee session, Dr. Qingbo Wang from The Second Hospital of Nanjing presented a report titled "Comprehensive Treatment Strategies for Tuberculosis-Associated Lung Cancer." The presentation explored the epidemiology, diagnostic challenges, and treatment strategies for patients with coexisting tuberculosis (TB) and lung cancer.
CCHIO 2024丨Dr. Xiaohua Wu: Enhancing Preoperative Evaluation Strategies for Advanced Ovarian Cancer Patients

CCHIO 2024丨Dr. Xiaohua Wu: Enhancing Preoperative Evaluation Strategies for Advanced Ovarian Cancer Patients

The historic city of Xi’an became a gathering place for top global oncologists as the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) and the Asian Oncology Socitey (AOS) took place from November 14 to 17. This event symbolized a significant integration of the global oncology community. During the gynecologic oncology session at CCHIO, Dr. Xiaohua Wu from Fudan University Shanghai Cancer Center delivered a presentation titled "Enhancing Preoperative Evaluation Strategies for Advanced Ovarian Cancer Patients." In an exclusive interview with Oncology Frontier, he shared Fudan's experience in advancing preoperative evaluation methods for ovarian cancer.